trial · primary record
1 tablet of Prenofitol
Dyslipidemia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 160 |
| Primary completion | 2027-12-31 |
| Primary endpoint | The proportion of patients achieving the target LDL-C level of <3.0 mmol/L compared with the baseline value in the investigational treatment groups and the placebo group at 90 days from the start of treatment (Visit 8). |
| Registry ID | NCT07908433 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:53.559Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908433
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.